BRCA1 and ovarian serous adenocarcinoma: A recent case–control study performed on thousands of cases and controls showed that constitutional methylation of BRCA1 gene promoter, detectable in blood cells is significantly associated with the risk of incident triple-negative breast cancers (TNBCs) and high-grade serous ovarian cancers (HGSOCs)7.